Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Thomas Pfisterer Insider Profile
4 Followers
Thomas Pfisterer, Director at ADC Therapeutics, holds 665.76K shares in ADC Therapeutics (Ticker: ADCT). Most recently, Thomas Pfisterer Sold $1,437 shares of ADC Therapeutics on Jun 18, 2024 for an estimated value of 4.15K.
Thomas Pfisterer has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Thomas Pfisterer's holdings
Insider Roles
Director
Roles that Thomas Pfisterer holds in companies
Most Profitable Insider Trade
The most profitable trade made by Thomas Pfisterer
Thomas Pfisterer's Trading History
List of latest transactions for each holding click on a transaction to see Thomas Pfisterer's performance on stock
You May Also Like
Thomas Pfisterer insider profile FAQ
What is the percentage of profitable transactions made by Thomas Pfisterer?
The percentage of profitable transactions made by Thomas Pfisterer is ―.
What is the average return per transaction made by Thomas Pfisterer?
The average return per transaction made by Thomas Pfisterer is ―.
What stocks does Thomas Pfisterer hold?
Thomas Pfisterer holds: ADCT stocks.
What was Thomas Pfisterer’s latest transaction?
Thomas Pfisterer latest transaction was an Informative Sell of $4.15K.
What was Thomas Pfisterer's most profitable transaction?
Thomas Pfisterer’s most profitable transaction was an Informative Sell of ADCT stock on June 18, 2024. The return on the trade was 26.80%.
What is Thomas Pfisterer's role in ADC Therapeutics?
Thomas Pfisterer's role in ADC Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.